Electrolyzed Hydrogen Water Protects against Ethanol-Induced Cytotoxicity by Regulating Aldehyde Metabolism-Associated Enzymes in the Hepatic Cell Line HepG2
Jinyun Wang, Satoshi Yano, Shigeru Kabayama, Taichi Hara
Read more:
DOI:
10.3390/antiox10050801
DOI is the universal ID for this study.
This link will take you to the full study.
Abstract:
Excessive alcohol consumption can cause multi-systemic diseases. Among them, alcoholic liver disease is the most frequent and serious disease. Electrolytic hydrogen water (EHW) is produced at the cathode during electrolysis of water and contains a large amount of molecular hydrogen and a low content of platinum nanoparticles with alkaline properties. In this study, we found that EHW inhibits ethanol-induced cytotoxicity by decreasing the intracellular acetaldehyde, a toxic substance produced by ethanol degradation, in hepatocyte cell lines HepG2. Analysis of the mechanism of action revealed that EHW inhibits the metabolism of ethanol to acetaldehyde by suppressing alcohol dehydrogenase. EHW also promotes the metabolism of acetaldehyde to acetic acid by activating aldehyde dehydrogenase, which plays to reduce aldehyde toxicity and intracellular reactive oxygen species in HepG2 cells. These functions were correlated with the concentration of molecular hydrogen in EHW, and were abolished by degassing treatment, suggesting that molecular hydrogen may contribute as a functional factor in the suppression of ethanol-induced hepatocellular damage. Furthermore, hydrogen water with high dissolved hydrogen molecule showed the same hepatocellular protective effect against ethanol as the EHW. These results suggest that EHW may be useful in the prevention of alcoholic liver disease.
| Publish Year |
2021 |
| Country |
Japan |
| Rank |
Positive |
| Journal |
Antioxidants |
| Primary Topic |
Liver |
| Secondary Topic | Liver Disease |
| Model |
Cell Culture |
| Tertiary Topic | Alcohol Toxicity |
| Vehicle |
Water (Electrolysis) |
| pH |
Alkaline |
| Application |
Culture Media |
| Comparison |
|
| Complement |
|
Hydrogen gas alleviates acute ethanol-induced hepatotoxicity in mice via modulating TLR4/9 innate ...
2023 - Liver - Fatty Liver Disease (Alcoholic)
Alcoholic liver disease (ALD), which is induced by chronic heavy alcohol consumption, accompanies complicated pathological mechanisms, including oxidative stress, inflammation, cell death, epigenetic changes and acetaldehyde-mediated toxicity. ...
Investigating the Effect of Hydrogen-Rich Water on Liver Cell Injury and Liver Cancer by Regulating ...
Background Liver cancer is an extremely heterogeneous malignant disease among tumors identified to date. In recent years, a large number of studies have found that low-concentration hydrogen or hydrogen-rich water or hydrogen-saturated physiological ...
The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q10 Levels and ...
2023 - Liver - Fatty Liver Disease (Nonalcoholic)
Molecular hydrogen (H2) has been recognized as a novel medical gas with antioxidant and anti-inflammatory effects. Non-alcoholic fatty liver disease (NAFLD) is a liver pathology with increased fat accumulation in liver tissue caused by factors other ...
Alleviating effects of hydrogen on hyperhomocysteinemia and fatty liver induced by high-methionine ...
2023 - Liver - Liver Disease
Objective: To investigate the alleviating effect of hydrogen (H2) on homocysteine (Hcy) levels and non alcoholic fatty liver in rats with hyperhomocysteinemia (HHcy). Methods: After one week of adaptive feeding, Wistar rats were randomly divided into ...
Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with ...
2023 - Liver - Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is a multisystem metabolic disease associated with gut microflora dysbiosis and inflammation. Hydrogen (H2) is a novel and effective antiinflammatory agent. The present study was aimed to clarify the effects ...
A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic ...
2022 - Liver - Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide with increasing incidence consistent with obesity, type 2 diabetes and cardiovascular diseases. No approved medication was currently available for NAFLD ...